Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Limin Pharmaceutical is a Chinese pharmaceutical company headquartered in Hefei, Anhui Province, and serves as a key subsidiary of Anhui Cubit Pharmaceutical. The company specializes in the development and large-scale manufacturing of traditional Chinese medicines (TCM) and chemical generic drugs. Its product portfolio is diverse, featuring well-known treatments for cardiovascular conditions, respiratory ailments, and pediatric care. Notable products include Compound Salvia Miltiorrhiza Tablets and Vitamin C Yinqiao Tablets, which are staples in the Chinese healthcare market. Hefei Limin operates state-of-the-art production lines that are fully compliant with national Good Manufacturing Practice (GMP) standards. As part of the Cubit Pharmaceutical group, the company benefits from an integrated platform spanning research, production, and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Limin Pharmaceutical.